Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
SMART goals translate vague aims into specific, measurable targets that guide budgeting, saving, and investing decisions.
23,411 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Regulators are weighing changes to mortgage asset rules, yet banks may take time to adjust. In the near term, mortgag...
PennyMac’s Third-Party Origination unit rolls out a seven-program non-QM suite to broaden options for borrowers with ...
HighTechLending and Better are joining forces to widen EquitySelect HELOC through NEO Home Loans, targeting homeowner...
A new Fed chair could reshape policy and markets. This guide explains chair kevin warsh plans, the potential economic...
Range secured an $8.3 million funding round this mid-June 2026, aimed at unifying fiat and stablecoin compliance on a...
Two fast-casual leaders are vying for investor attention in 2026. This deep dive compares CAVA Group and Chipotle Mex...
Microsoft stock pulled back early in 2026, turning headlines into a real question for investors: down 15%, should mic...
An equal-weight large-cap ETF is gaining attention as a retirement-friendly alternative to cap-weighted funds. Here’s...
Elon Musk has appointed Benji Taylor, formerly with Base and Aave, to head design for X as the platform races to inte...
As Bitcoin hovers in the mid-$30,000s in June 2026, investors ask whether will bitcoin make millionaire? fortunes pos...
A breakthrough blood test that screens for 50+ cancers is edging toward real-world use. This article breaks down what...